Quantifying disease-specific symptom improvement after parathyroid and thyroid surgery using patient-reported outcome measures - 28/08/22
, Talia Burneikis, Samuel J. Zolin, Salem I. Noureldine, Judy Jin, Eren Berber, Vikram D. Krishnamurthy, Joyce Shin, Allan SipersteinAbstract |
Background |
Patient-reported outcome measures for parathyroid and thyroid disease (PROMPT) is a 30-question, previously validated, survey assessing symptoms on a scale from 0 to 100. Using PROMPT, we aimed to assess symptom improvement for patients undergoing thyroidectomy and parathyroidectomy.
Methods |
Single-center prospective study in which PROMPT was used to assess symptom improvement in patients undergoing parathyroidectomy or thyroidectomy. A postoperative assessment was performed approximately 6 months after surgery and compared to its baseline preoperative assessment.
Results |
A total of 144 patients completed both assessments (71 parathyroidectomy, 73 thyroidectomy). Parathyroidectomy patients demonstrated significant improvements in all hyperparathyroidism domains (38.2–28.3, p < 0.001) regardless of preoperative calcium and parathyroid hormone levels. Thyroidectomy patients experienced improvement in their compressive symptoms (25.6–16.5, p < 0.001).
Conclusions |
PROMPT objectively demonstrates the clinical effectiveness of parathyroidectomy and thyroidectomy in alleviating subjective patient symptoms. PROMPT offers promising use as a standardized metric to assess quality of life improvement within endocrine surgery.
Le texte complet de cet article est disponible en PDF.Highlights |
• | PROMPT can objectively demonstrate the clinical effectiveness of parathyroidectomy and thyroidectomy. |
• | PROMPT can objectively demonstrate the clinical effectiveness of parathyroidectomy regardless of the biochemical profile. |
• | PROMPT can help evaluate patients in a high-volume clinic with mixed thyroid and parathyroid disease states. |
Keywords : Thyroidectomy, Parathyroidectomy, Patient reported outcomes
Plan
Vol 224 - N° 3
P. 923-927 - septembre 2022 Retour au numéro
Article précédent
- Is preoperative parathyroid localization necessary for tertiary hyperparathyroidism?
- Rongzhi Wang, Peter Abraham, Brenessa Lindeman, Herbert Chen, Jessica Fazendin
- A prospective study evaluating the use of low-dose intravenous sedation and analgesia during radiofrequency ablation of symptomatic, benign thyroid nodules
- Matrix Man Him Fung, Brian HH. Lang
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?